Low dose of extracellular vesicles identified that promote recovery after ischemic stroke

BACKGROUND: Mesenchymal stem cell-derived extracellular vesicles (EVs) are one of the most promising therapeutics in protective and/or regenerative therapy in animal models of stroke using a dose of 100 μg. However, whether EVs dose is related to outcomes is not known. This study aimed to identify t...

Descripción completa

Detalles Bibliográficos
Autores principales: Otero-Ortega, Laura, Laso-García, Fernando, Frutos, Mari Carmen Gómez-de, Diekhorst, Luke, Martínez-Arroyo, Arturo, Alonso-López, Elisa, García-Bermejo, María Laura, Rodríguez-Serrano, Macarena, Arrúe-Gonzalo, Mercedes, Díez-Tejedor, Exuperio, Fuentes, Blanca, Gutiérrez-Fernández, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029550/
https://www.ncbi.nlm.nih.gov/pubmed/32075692
http://dx.doi.org/10.1186/s13287-020-01601-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029550/
https://www.ncbi.nlm.nih.gov/pubmed/32075692
http://dx.doi.org/10.1186/s13287-020-01601-1

Ejemplares similares